Review of AAPM Task Group No. 43 recommendations on interstitial brachytherapy sources dosimetry. American Association of Physicists in Medicine.

[1]  B. Prestidge,et al.  Clinical impact of implementing the recommendations of AAPM Task Group 43 on permanent prostate brachytherapy using 125I. American Association of Physicists in Medicine. , 1998, International journal of radiation oncology, biology, physics.

[2]  J. Williamson,et al.  Report of the ad hoc committee of the AAPM radiation therapy committee on 125I sealed source dosimetry. , 1998, International journal of radiation oncology, biology, physics.

[3]  J. Blasko,et al.  A method for implementing the American Association of Physicists in Medicine Task Group-43 dosimetry recommendations for 125I transperineal prostate seed implants on commercial treatment planning systems. , 1997, International journal of radiation oncology, biology, physics.

[4]  S. Nag.  Principles and practice of brachytherapy , 1997 .

[5]  L. Anderson,et al.  Dosimetry of interstitial brachytherapy sources: Recommendations of the AAPM Radiation Therapy Committee Task Group No. 43 , 1995 .

[6]  J F Williamson,et al.  Clinical implementation of AAPM Task Group 32 recommendations on brachytherapy source strength specification. , 1991, Medical physics.

[7]  Lowell L. Anderson,et al.  Interstitial Brachytherapy: Physical, Biological, and Clinical Considerations , 1990 .

[8]  Jeffrey Williamson,et al.  Specification of Brachytherapy Source Strength , 1987 .

[9]  F. Khan.  The physics of radiation therapy , 1985 .

[10]  J. S. Laughlin,et al.  The Physics of Radiology. 4th ed , 1984 .

[11]  H. E. Johns,et al.  Physics of Radiology , 1983 .

[12]  L. L. Meisberger,et al.  The effective attenuation in water of the gamma rays of gold 198, iridium 192, cesium 137, radium 226, and cobalt 60. , 1968, Radiology.